CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Haw Par Corporation Limited Company Snapshot
Haw Par Corporation Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Haw Par Corporation Limited with three other pharmaceutical manufacturers in Asia: Huons Global Co Ltd of South Korea (2016 sales of 163.71 billion Korean Won [US$145.54 million] of which 112% was Pharmaceutical Department), Chongqing Lummy Pharmaceutical Co Ltd of China (990.18 million Chinese Renmimbi [US$146.78 million] of which 98% was Chemical Manufacturing), and Autobio Diagnostics Co Ltd which is also based in China (980.22 million Chinese Renmimbi [US$145.31 million] of which 95% was In vitro diagnosis).

Sales Analysis. Haw Par Corporation Limited reported sales of 201.64 million Singapore Dollars (US$147.62 million) for the year ending December of 2016. This represents an increase of 12.8% versus 2015, when the company's sales were 178.83 million Singapore Dollars. Sales at Haw Par Corporation Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 52%). Sales of Property Rental saw an increase of 24.7% in 2016, from 13.53 million Singapore Dollars to 16.87 million Singapore Dollars. Not all segments of Haw Par Corporation Limited experienced an increase in sales in 2016: sales of Leisure Products and Services fell 34.2% to 8.39 million Singapore Dollars.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Haw Par Corporation Limited
  Stock Performance Chart for Haw Par Corporation Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 10.82
(Figures in Singapore Dollars)
1 Week -0.1%   13 Weeks -4.2%  
4 Weeks 8.6%   52 Weeks 20.9%  
 
Haw Par Corporation Limited Key Data:
  Ticker: H02 Country: Singapore
  Exchanges: HKG KUL SIN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 201,644,000
(Year Ending Jan 2017).
Employees: 513
  Currency: Singapore Dollars Market Cap: 2,376,593,232
  Fiscal Yr Ends: December Shares Outstanding: 219,648,173
  Share Type: Ordinary Closely Held Shares: 78,330,942
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.